News
But this time, the unknown is hitting the industry in a different way from when Prasad was tapped to lead CBER less than ...
This week on "The Readout LOUD," STAT's biotech reporters parse what Vinay Prasad's ouster means for biotech and the FDA.
U.S. Food and Drug Administration officials should encourage the thoughtful and careful evaluation of drugs.
Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...
Vinay Prasad is my former student and friend. His departure from FDA is a loss for American medicine
It is hard to imagine someone more equipped and more dedicated to vetting treatments than Vinay Prasad,” writes his former ...
A top FDA appointee who doesn’t think patients can be trusted to make their own healthcare decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results